Bridgeway Capital Management’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
Other funds holding INO
Bridgeway Capital Management's INO Position: Q3 2026 in Review
Bridgeway Capital Management sold out of Inovio Pharmaceuticals (INO) in Q3 2026, closing a stake of 173,000 shares — an estimated $190K sold.
Bridgeway Capital Management first reported a position in INO in Q3 2013 and held it in 6 quarters. The position peaked at $301K in Q1 2026. 110 funds tracked by Wall St. Rank hold INO as of Q3 2026.
- Bridgeway Capital Management reported no remaining Inovio Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Bridgeway Capital Management sold 173,000 Inovio Pharmaceuticals shares in Q3 2026, an estimated $190K.
- Bridgeway Capital Management first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 6 quarters.
- Bridgeway Capital Management's Inovio Pharmaceuticals position peaked at $301K in Q1 2026.
- 110 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q3 2026.
Based on Bridgeway Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.